Mercer Global Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Sell
12,665
-5,740
-31% -$134K ﹤0.01% 2759
2026
Q1
$258K Buy
18,405
+3,041
+20% +$41K ﹤0.01% 2585
2025
Q4
$173K Sell
15,364
-2,875
-16% -$32.9K ﹤0.01% 2609
2025
Q3
$211K Buy
+18,239
New +$214K ﹤0.01% 2358

Other funds holding AVNS

Mercer Global Advisors's AVNS Position: Q2 2026 in Review

Mercer Global Advisors reduced its Avanos Medical (AVNS) stake by 31% in Q2 2026, selling an estimated $134K and leaving 12,665 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #2759.

Mercer Global Advisors first reported a position in AVNS in Q3 2025 and has held it in 4 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Mercer Global Advisors held 12,665 shares of Avanos Medical worth $315K as of Q2 2026.
  • Mercer Global Advisors sold 5,740 Avanos Medical shares in Q2 2026, an estimated $134K.
  • Avanos Medical made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2759 holding.
  • Mercer Global Advisors first reported a position in Avanos Medical in Q3 2025 and has held it in 4 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.